BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Press Releases

News for BIO-Europe® 2014 will be available soon

BIO-Europe 2013 press releases

November 14, 2013BIO-Europe® 2013 breaks all previous records for attendance and partnering The 19th annual BIO-Europe® international partnering conference (November 4–6) wrapped up last week in Vienna, Austria. The conference, organized by EBD Group in collaboration with the Biotechnology Industry Organization (BIO) and local host Life Science Austria Vienna (LISAvienna), featured nearly 18,000 one-to-one partnering meetings, an all-time record. Over 3,200 del...  more ►

October 7, 2013Tony Coles, Former Onyx Pharmaceuticals Chairman and CEO, to give keynote at BIO-Europe® 2013 in Vienna November 4–6 Tony Coles, MD, Former Chairman and CEO of Onyx Pharmaceuticals, Inc., will give the opening keynote at the 19th annual BIO-Europe® international partnering conference in Vienna, Austria, November 4–6, 2013. Coles' presentation, "The Onyx Story: Creating a Leading Oncology Company," is expected to be a big draw at the event just as Amgen and Onyx Pharmaceuticals close th...  more ►

September 11, 2013Get the most out of your partnering meetings at BIO-EuropeRead these Partnering Tips from big pharma on how to have an effective partnering meeting.
TIP 1 "We don't expect the work you do to be perfect or fully comprehensive to gain our interest, however make sure whatever you do is of high quality." – Rob Wills, VP, Alliance Management, Janssen Pharmaceuticals. TIP 2 "Know your competitors and be ready to pitch your competitive advantage all the time." – Thomas Hanke, Director, Biopharmaceuticals Innovation Sourcing...  more ►

September 5, 2013BIO-Europe® 2013 program is packed with well-known dealmakersExecutives from pharma and biotech to attend Vienna partnering event
November 4–6

Pharmaceutical executives and leaders in biotech are on board to speak at the 19th annual BIO-Europe® international partnering conference in Vienna, Austria, November 4–6, 2013. Organized by EBD Group in collaboration with the Biotechnology Industry Organization and local host Life Science Austria Vienna (LISAvienna), the event is Europe's largest partnering conference servi...  more ►

June 27, 2013Life science dealmaking is the main focus at BIO-Europe® 2013 to be held in Vienna November 4–6 The 19th annual BIO-Europe® international partnering conference will be held in Vienna, Austria, November 4–6, 2013 at the Messe Wien Exhibition and Congress Center. The fall event is organized by EBD Group in collaboration with local host Life Science Austria Vienna (LISAvienna), the life science cluster of the Republic of Austria and the City of Vienna. "Vienna's life ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

23 July 2014 Medtrack Unpartnered Products – Partnerships that could be Game Changers As the pharmaceutical landscape continues to consolidate through acquisitions and partnerships, Medtrack Analyst Steven Muntner examines the untapped market of unpartnered products, which represents a potential multi-billion dollar opportunity. more ►

22 July 2014 Promethera expands portfolio with progenitor cell platform Eric Halioua arrives at BioPharm America™ in Boston this September carrying an expanding portfolio of partnering opportunities based on a platform of human liver progenitor cells. more ►

22 July 2014 CoStim Pharma: People plus hot science create stunning combo-combo deal Pathways and platforms are great but true exits come around product portfolios, says Robert Millman, a founder and the chief executive for CoStim Pharmaceuticals, which was snapped up by Novartis just 10 months after the company's first funding round. more ►

21 July 2014 Recent industry analysis on distribution partnering agreements Recent industry analysis from Current Agreements shows a high volume of dealmaking activity in the distribution deal type among the pharma and biotech companies worldwide. more ►

12 May 2014 Market Update: Cancer Immunotherapy Perhaps no other recent topic in oncology has generate as much excitement as the immunotherapies. PD-1s, checkpoint inhibitors, CAR-T, and DC therapies – all have become common fare for those following cancer drug development. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe EBD Group BIO BIO-Europe